head and neck cancer

Research Reports

Development of a Low Resource Tool for Optimizing Head and Neck Cancer Treatment Delivery Within an Integrated Health Care Delivery System

10/18/2019

Robert Parke , MD;

David Hernandez , MD;

Anita L. Sabichi , MD;

Vlad C. Sandulache , MD, PhD;

Peter Gerngross , DDS;

Ricky Morlen , DMD;

George Chen , MD;

Caroline Hudson , MD;

David C. Wilde , MD;

Andrew T. Huang , MD;

Banner Logan , DDS, MD;

Scott Charnitsky , PA;

Abstract: The Veterans Health Administration is the largest nationally integrated health care delivery system in the United States, making it an ideal environment for development of tools designed to streamline cancer diagnosis and...

Abstract: The Veterans...

10/18/2019

Journal of Clinical Pathways

News

Nanobiotix Partner PharmaEngine Launches NBTXR3 Clinical Trial in Head and Neck Cancers in Asia

10/26/2016

Seventh clinical trial with NBTXR3 in a new population of patients with head and neck cancers treated with radiotherapy plus chemotherapyParis, France, and Cambridge, Massachusetts, USA, October 20, 2016 – NANOBIOTIX (Euronext: NANO – ISIN:...

Seventh clinical trial with...

10/26/2016

IO Learning

Research in Review

Nivolumab Superior to Standard Therapy for Recurrent Head and Neck Cancer

10/14/2016

JCP Editors

Patients with recurrent or metastatic squamous-cell carcinoma of the head and neck may benefit more from treatment with nivolumab than standard, single agent therapy, according to results from a trial published in...

...

10/14/2016

Journal of Clinical Pathways

News

Postoperative Stereotactic Radiosurgery a New Standard of Care for Patients With Resected Brain Metastases

09/27/2016

Newswise — BOSTON, September 25, 2016 -- For patients who have cancer that has metastasized to the brain, stereotactic radiosurgery (SRS) results in statistically comparable survival rates, reduced cognitive decline and better quality of life...

Newswise — BOSTON, September 25,...

09/27/2016

IO Learning

News

Stereotactic Radiosurgery Decreases Rate of Postoperative Local Recurrence for Brain Metastases

09/27/2016

Alternative to whole brain radiation therapy improved local control but did not augment overall survival or rate of distant metastasesNewswise — BOSTON, September 25, 2016 -- Stereotactic radiosurgery (SRS) for cancer patients who receive the...

Alternative to whole brain...

09/27/2016

IO Learning

Research in Review

Systemic Therapy Use Growing Among Elderly Patients With Head and Neck Cancer

08/12/2016

JCP Editors

Despite conflicting prospective evidence, most elderly patients with locoregionally advanced head and neck cancer treated with definitive radiotherapy also receive systemic therapy, according to results from a study...

...

08/12/2016

Journal of Clinical Pathways

Nivolumab More than Doubles One-Year Overall Survival in Head/Neck Cancer

04/27/2016

JCP Editors

Treatment with nivolumab reduced the risk of death and improved one-year overall survival (OS) compared with investigator’s choice of therapy for patients with recurrent or metastatic head and neck squamous cell...

...

04/27/2016

Journal of Clinical Pathways

Research in Review

Number of Positive Nodes Best Prognostic Indicator for Patients With Head and Neck Cancer

04/11/2016

JCP Editors

The number of positive nodes is a better indicator of prognosis in patients with head and neck cancer than lymph node ratio and the American Joint Committee on Cancer (AJCC) staging system, according to a recent...

The...

04/11/2016

Journal of Clinical Pathways

Research in Review

HPV-16 Associated with Better Overall Survival in Patients With Head and Neck Cancer

03/31/2016

JCP Editors

The presence of human papillomavirus-16 (HPV-16) is associated with higher rates of overall survival in patients with head and neck squamous cell carcinoma (HNSC), suggesting it may be a more effective prognostic...

The...

03/31/2016

Journal of Clinical Pathways

Research in Review

PET-CT Scans More Cost-Effective Than Surgery for Head and Neck Cancer

03/28/2016

JCP Editors

Surveillance using positron emission tomography-computed tomography (PET-CT) scans can be a cost-effective and safe alternative to invasive neck dissection for certain patients with head and neck cancer (HNC),...

...

03/28/2016

Journal of Clinical Pathways